Charles Schwab’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $47.7K | Hold |
|
|||||
|
2023
Q2 | $12.3K | Hold |
|
|||||
|
2023
Q1 | $16.2K | Hold |
|
|||||
|
2022
Q4 | $19.9K | Hold |
|
|||||
|
2022
Q3 | $28K | Hold |
|
|||||
|
2022
Q2 | $43K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $53K | Hold |
|
|||||
|
2021
Q3 | $77K | Hold |
|
|||||
|
2021
Q2 | $96K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $220K | Hold |
|
|||||
|
2019
Q4 | $347K | Hold |
|
|||||
|
2019
Q3 | $434K | Buy |
|
|||||
|
2019
Q2 | $714K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $167K | Hold |
|
|||||
|
2017
Q4 | $241K | Hold |
|
|||||
|
2017
Q3 | $161K | Hold |
|
|||||
|
2017
Q2 | $326K | Buy |
|